Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
amgen
biotech
calcitonin gene-related peptide
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
chronic migraine
detroit blog main
detroit top stories
drugs
episodic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
medicine
migraine
migraine research foundation
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
What
class
7
×
drug
7
×
new
7
×
approval
fda
migraine
won
amgen
big
companies
developed
discovery
fewer
late
medicines
mice
pain
prevent
starts
year
adapting
announced
antidepressant
antidepressants
approved
arguments
available
away
begins
called
candidates
cofactor
commercialized
common
company
competitors
conducted
consumer
crippling
days
Language
unset
Current search:
class
×
new
×
drug
×
@bgr.com
1 year ago
This new type of antidepressant drug was found to work in just 2 hours
@extremetech.com
2 years ago
New Drug Class Reverses Paralysis in Mice
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@theverge.com
7 years ago
This new drug promises fewer days a month with migraines
@WIRED
8 years ago
Cofactor is an RNA sequencing company that's turning away from drug discovery for big pharma toward consumer diagnostics.